Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
4K televisions for Extreme Film Watching Experience - 2Multi-million-euro win in Spanish lottery in doubt due to oversight
- 3A definitive Manual for Internet Mastering and Expertise Improvement
- 4World's oldest known tortoise still very much alive despite rumor to the contrary
- 5Herzog, German Chancellor Merz discuss final Gaza hostage, Arrow 3 exchange in Jerusalem
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- From School Dropout to Example of overcoming adversity: My Excursion
- Why screening for the deadliest cancer in the U.S. misses most cases
- Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes
- Holden Commodore Turbo BT1 Police Interceptor Offered for Sale in Australia
- What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
- The cheap health insurance promoted by Trump officials has this catch
- Netflix's 'Lord of the Flies' show blends 'Adolescence' and 'Yellowjackets'
- RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object.
